Plasma homocysteine concentrations in patients with type 1 diabetes

Diabetes Care

Volumn 21, Issue 11, 1998, Pages 1843-1847

  Cronin, Cornelius C ^a,d   Mcpartlin, Joseph M ^b   Barry, Don G ^c   Barry Ferriss, J ^a   Scott, John M ^b   Weir, Donald G ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF LIMERICK   (Ireland)

^d University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; AGING; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; FEMALE; GENDER; HOMOCYSTINURIA; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; RISK FACTOR;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; FOLIC ACID; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; MALE; MICROCIRCULATION;

EID: 0031754566     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.11.1843     Document Type: Article

References (34)

1. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 59:8-13, 1979
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study BMJ 287:867-870, 1983
3. Scott J, Weir D: Homocysteine and cardiovascular disease. Q J Med 89:561-563, 1996
4. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV Hennekens CH: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992
5. Molgaard J, Malinow MR, Lassvik C, Holm AC, Upson B, Olsson AG: Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication. J Intern Med 231:273-279, 1992
6. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P: Elevated plasma homocyst(e)ine concentration as a possible risk factor for stroke. Stroke 21:572-576, 1990
7. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S. Fowler B, Graham I: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149-1155, 1991
8. van den Berg M, Boers GHJ, Franken DG, Blom HJ, van Kamp GJ, Jakobs C, Rauwerda JA, Kluft C, Stehouwert CDA: Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 25:176-181, 1995
9. Schreiner PJ, Wu KK, Malinow MR, Nieto FJ, Heiss G: Plasma homocyst(e)ine and hemostasis: the ARIC Study (Abstract). Circulation 89:511, 1994
10. Heinecke JW, Rosen H, Suzuki LA, Chait A: The role of sulfur-containing amino acids in Superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem 262:1098-1103, 1987
11. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME: Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A 91:6369-6373, 1994
12. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Decken T: Features of endothelial dysfunction in early diabetic nephropathy Lancet i:461-463, 1989
13. Kwaan HC: Changes in blood coagulation, platelet function and plasminogen-plasmin system in diabetes. Diabetes 41 (Suppl. 2):32-35, 1992
14. Tsai EC, Hirsch IB, Brunzell JD, Chait A: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43:1010-1014, 1994
15. Stout RW. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 90 (Suppl. 2A):62S-65S, 1991
16. Hultberg B, Agardh E, Andersson A, Brattstrom L, Isaksson A, Israelsson B, Agardh C-D: Increased levels of plasma homocysteine are associated with nephropathy but not severe retinopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 51:277-282, 1991
17. Robillon JF, Canivet B, Candito M, Sadoul JL, Jullien D, Morand R Chambon R Freychet P: Type 1 diabetes mellitus and homocyst(e)ine. Diabete Metab 20:494-496, 1994
18. Agardh C-D, Agardh E, Andersson A, Hultberg B: Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 54:637-641, 1994
19. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W Ziegler R, Wahl P. Nawroth PP: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 20:1880-1886, 1997
20. The EURODIAB IDDM Complications Study Group: Microvascular and acute complications in insulin dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285, 1994
21. Cronin CC, Ferriss JB, Stephenson JM, Crowley B, Whyte A, Cleary PE: Complications and cardiovascular risk factors in insulin-dependent diabetes: findings in an Irish clinic and in other European centres. Ir J Med Sci 163:496-500, 1994
22. Cronin CC, Barry D, Crowley B, Ferriss JB: Reduced plasma aldosterone concentrations in randomly selected patients with insulin-dependent diabetes mellitus. Didbet Med 12:809-815, 1995
23. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH: Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39:1764-1779, 1993
24. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high performance chromatography with fluorescent detection. J Chromatogr 422: 43-52, 1987
25. Ubbink JB, Hayward Vermaak WJ, Bissbort S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446, 1991
26. O'Brion S, Kelleher B: Microbiological assay on microlitre plates of folate in serum and red cells, J Clin Pathol 45:344-347, 1992
27. John WG, Gray MR, Bates DL, Beacham JL: Enzyme immunoassay: a new technique for estimating hemoglobin Alc. Clin Chem 39:663-666, 1993
28. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B: Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status, Eur J Clin Invest 22:79-87, 1992
29. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 236:633-641, 1994
30. Chadefaux B, Rethore MO, Raoul O, Ceballos I, Poissonnier M, Gilgenkranz S, Allard D: Cystathionine beta synthase: gene dosage effect in trisomy 21. Biochem Biophys Res Commun 128:40-44, 1985
31. Foreman JW, Wald H, Blumberg G, Pepe LM, Segal S: Homocystine uptake in isolated rat renal cortical tubules, Metabolism 31:613-619, 1982
32. Humphreys M, Cronin CC, Barry DG, Ferriss JB: Are the nutritional recommendations for insulin-dependent diabetic patients being achieved? Diabet Med 11:79-84, 1994
33. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050, 1998
34. Stampfer MJ, Malinow MR: Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 332:328-329, 1995